PCOS

1
Pipeline Programs
2
Companies
2
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
1
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

2 companies ranked by most advanced pipeline stage

City Therapeutics
City TherapeuticsMA - Cambridge
1 program
1
Metformin and SpironolactonePhase 2/31 trial
Active Trials
NCT03981861CompletedEst. Jun 2019
Genesis Therapeutics
Genesis TherapeuticsCA - Burlingame
1 program
mode of gonadotropin administrationN/A1 trial
Active Trials

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
City TherapeuticsMetformin and Spironolactone
Genesis Therapeuticsmode of gonadotropin administration

Clinical Trials (2)

NCT03981861City TherapeuticsMetformin and Spironolactone

Metabolic and Neuro-Endocrine Effect of Treating PCOS in Adolescents

Start: Jul 2016Est. completion: Jun 2019
Phase 2/3Completed
NCT01112111Genesis Therapeuticsmode of gonadotropin administration

A Novel Stimulation Protocol and the Conventional Low Dose Step-up and Step Down Regimens

Start: May 2010
N/AUnknown

Phase Legend

PreclinicalLab & animal studies
Phase 1Safety & dosing
Phase 2Efficacy testing
Phase 3Large-scale trials
On MarketApproved & available

Key Insights

2 companies competing in this space